No consideration of sustainability adverse impacts

While the Fund Manager, Sunstone Life Science Ventures A/S (“Sunstone”) does consider sustainability risks in its investment decisions, Sunstone does not consider all of the specific adverse impact indicators set out in Table 1-3 of Annex 1 of the Commission’s delegated regulation supplementing Regulation (EU) 2019/2088 (the Sustainable Finance Disclosure Regulation) in its investment decisions.

The reason for this is that Sunstone has decided to focus on a few specific sustainability risk indicators fit for each investment profile of its respective Funds under management (as defined below) rather than consider all of the indicators set out in Table 1-3 of Annex 1. Sunstone will, however, on a continuous basis assess whether to consider all of the specific adverse impact indicators set out in Table 1-3 of Annex 1 in its investment decisions.

Funds under management

Sunstone Life Science A/S, CVR-no. 33859198 “Sunstone” has the following alternative investment funds under management:

K/S Sunstone Biomedical Venture Annex I, CVR-no. 27513468

K/S Sunstone Biomedical Venture Annex II, CVR-no. 27919995

K/S Sunstone Biomedical Venture Annex III, CVR-no. 27513492

P/S Sunstone Biomedicinsk Venture III, CVR-no. 25884132

Sunstone Life Science Ventures Fund II K/S, CVR-no. 30582268

Sunstone Life Science Ventures Fund III K/S, CVR-no. 34085919

Sunstone Life Science Ventures Fund IV K/S, CVR-no. 38778536

The alternative investment funds listed above are for the purposes hereof referred to as the “Funds”.

 

Published 10 March 2021